Key result
International consensus documents recommended PCI as the reperfusion method of choice, while three of four national statements recommended fibrinolysis for STEMI in suspected/confirmed COVID-19.
Why the study?
During the early phase of the COVID-19 pandemic, the safe and effective management of medical emergencies such as STEMI was a challenge.
Systematic Review (n=6)
This systematic review highlights the divergence in early COVID-19 STEMI guidelines, with international societies favoring primary PCI and several national societies recommending a fibrinolysis-first approach.
Answers are grounded in this paper and cite their sources.
Divergent guidelines risk inconsistent STEMI reperfusion during outbreaks; challenges harmonization of international and national recommendations.
Background: Coronavirus disease 2019 (COVID-19) had a major impact on healthcare systems worldwide. During the early phase of the pandemic many elective procedures were postponed. At the same time, the safe and effective management of medical emergencies such as ST-segment elevation myocardial infarction (STEMI) has been a challenge. Methods: A systematic literature search was conducted aiming to identify published guidance reports by national or international societies regarding the management of patients suffering STEMI in the era of COVID-19. Results: Among 1681 articles initially retrieved, six fulfilled the inclusion criteria and were included in the systematic review. Two reports were international consensus documents, while four reports were national guidance statements from Asian countries (Taiwan, India, Iran, and China). Most documents were drafted during the early phase of the pandemic. According to the international consensus documents, percutaneous coronary intervention (PCI) should be regarded as the reperfusion method of choice. On the other hand, in three out of four national consensus statements (Taiwan, Iran and China) fibrinolysis was considered as the reperfusion method of choice for STEMI in suspected/confirmed patients with COVID-19, unless contraindicated or in the presence of high cardiovascular risk clinical features. Authors of all documents underlined the need for early COVID-19 testing in patients with STEMI to better determine the next therapeutical steps. Conclusions: National and international consensus statements for STEMI management in the era of COVID-19 have been published mainly during the early peak phase of the pandemic. Authors recognise that these recommendations are mainly based on expert opinions and observational data. As global immunization rates increase and methods for rapid COVID-19 detection are widely available, the implementation of traditional evidence-based practices used before the pandemic is becoming more feasible.
No takes yet. Share an insight, caveat, or question.
Kyriakoulis et al. (2023) conducted a systematic review in ST-segment elevation myocardial infarction (STEMI) during COVID-19 (n=6). Guidance reports on STEMI management (PCI vs Fibrinolysis) was evaluated on Recommended reperfusion strategy. International consensus documents recommended PCI as the reperfusion method of choice, while three of four national statements recommended fibrinolysis for STEMI in suspected/confirmed COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: